Remote Blood-Draw Dried-Spot Device Market Report 2026

Remote Blood-Draw Dried-Spot Device Market Overview

• Remote Blood-Draw Dried-Spot Device market size has reached to $0.92 billion in 2025 • Expected to grow to $1.73 billion in 2030 at a compound annual growth rate (CAGR) of 13.2% • Growth Driver: Rising Focus On Personalized Medicine Driving The Market Growth Due To At-Home Genetic And Biomarker Monitoring • Market Trend: Advancements In Remote And Decentralized Blood Sampling Technologies • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Remote Blood-Draw Dried-Spot Device Market?

A remote blood-draw dried-spot device is a medical device that collects small blood samples from patients remotely, often at home, onto special filter paper or absorbent material. The collected dried blood spots can then be safely transported to a laboratory for analysis, enabling convenient monitoring of health parameters without traditional venous blood draws. The main product types of remote blood-draw dried-spot devices are filter paper devices, microfluidic devices, and others. Filter paper devices are designed to collect and preserve small blood samples on treated paper, enabling convenient, stable, and transportable dried blood spot testing. Supported sample types include whole blood, plasma, serum, and others and are distributed through direct sales, online retail, pharmacies, and others. They are used in applications such as disease diagnosis, therapeutic drug monitoring, newborn screening, forensic testing, and others, serving end users including hospitals and clinics, diagnostic laboratories, research institutes, home care settings, and others.

What Is The Remote Blood-Draw Dried-Spot Device Market Growth Forecast?

The remote blood-draw dried-spot device market size is expected to see rapid growth in the next few years. It will grow to $1.73 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to home healthcare expansion, chronic disease monitoring, digital pathology growth, logistics optimization, population health management. Major trends in the forecast period include at-home blood sample collection, mail-in diagnostic testing, minimal invasive sampling devices, microfluidic blood collection, decentralized diagnostic testing.

Global Remote Blood-Draw Dried-Spot Device Market Segmentation

1) By Product Type: Filter Paper Devices, Microfluidic Devices, Other Product Types 2) By Sample Type: Whole Blood, Plasma, Serum, Other Sample Types 3) By Distribution Channel: Direct Sales, Online Retail, Pharmacies, Other Distribution Channels 4) By Application: Disease Diagnosis, Therapeutic Drug Monitoring, Newborn Screening, Forensic Testing, Other Applications 5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Home Care Settings, Other End-Users Subsegments: 1) By Filter Paper Devices: Whole Blood Collection Cards, Plasma Separation Cards 2) By Microfluidic Devices: Integrated Microchannel Systems, Capillary-Driven Microfluidic Chips 3) By Other Product Types: Volumetric Absorptive Micro sampling Devices, Capillary Blood Collection Tubes

What Is The Driver Of The Remote Blood-Draw Dried-Spot Device Market?

The increasing emphasis on personalized medicine is expected to propel the growth of the remote blood-draw dried-spot device market going forward. Personalized medicine refers to tailoring medical treatment and prevention strategies to an individual’s genetic, molecular, and clinical characteristics for optimal outcomes. The adoption of personalized medicine is increasing as advances in genomics allow precise identification of genetic variations affecting disease risk and treatment response, enabling more effective and targeted therapies. Remote blood-draw dried-spot devices help personalized medicine by enabling convenient, at-home collection of small blood samples, allowing frequent monitoring of biomarkers and genetic information to guide tailored treatment and therapy decisions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, the increasing emphasis on personalized medicine is driving the growth of the remote blood-draw dried-spot device industry.

Key Players In The Global Remote Blood-Draw Dried-Spot Device Market

Major companies operating in the remote blood-draw dried-spot device market are Neoteryx Inc., DBS System SA, Tasso Inc., Capitainer AB, Spot On Sciences Inc., HemaXis S.A., Drawbridge Health Inc., RDA Spot Inc., YourBio Health Inc., Lipomic Healthcare Inc., Trajan Scientific and Medical Pty Ltd., Salimetrics LLC, Eastern Business Forms Inc., PanoHealth Inc., RedDrop Dx Inc., Nanowear Inc., Bioanalytical Systems Inc., Phenomenex Inc., Greiner Bio-One International GmbH, Whatman (Cytiva)

Global Remote Blood-Draw Dried-Spot Device Market Trends and Insights

Major companies operating in the remote blood-draw dried-spot device market are focusing on developing advanced approaches, such as decentralized sampling to enable at-home or remote blood collection, improve patient convenience, and enhance clinical trial efficiency. Decentralized sampling refers to the process of obtaining biological specimens at locations convenient for the patient rather than at centralized laboratories or clinics, enabling broader access, faster collection, and more flexible participation in healthcare or research studies. For instance, in March 2025, Tasso Inc., a US-based healthcare technology company, launched a next-generation technology for dried blood spot (DBS) sample collection, designed primarily for clinical trials and sports anti-doping testing. This technology provides a virtually painless, convenient, and precise method for blood sampling, ideal for clinical trials and sports anti-doping testing. It delivers accurate volumetric blood samples using a patient-friendly device, improving compliance and enabling remote collection. By simplifying the sampling process, lowering participation barriers, and generating high-quality quantitative data, it accelerates drug development and supports decentralized testing models.

What Are Latest Mergers And Acquisitions In The Remote Blood-Draw Dried-Spot Device Market?

In April 2025, Boston, a US-based biotechnology company, partnered with Nanowear Inc. to develop advanced wearable biosensors for continuous health monitoring. With this partnership aims to revolutionize home-based healthcare by integrating AI-powered nanotechnology diagnostics with blood-based diagnostics and drug delivery patches to provide precise, continuous, and patient-friendly diagnostics and therapeutics through a single digital platform, accelerating the shift from clinic-centered to decentralized personalized care. Nanowear Inc. is a US-based technology company that offers a remote blood-draw dried-spot device.

Regional Outlook

North America was the largest region in the remote blood-draw dried-spot device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Remote Blood-Draw Dried-Spot Device Market?

The remote blood-draw dried-spot device market consists of sales of capillary blood collection kits, prepaid sample mailers, and integrated smart collection devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.